30
May
2013
Transparency of measures regulating the prices of medicinal products
Opinion on the amended Commission proposal for a Directive on the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems
Available languages: German, English, French
Executive Summary
Available languages: Bulgarian, Czech, Danish, German, Estonian, Greek, English, Spanish, French, Croatian, Italian, Latvian, Lithuanian, Hungarian, Maltese, Dutch, Polish, Portuguese, Romanian, Slovak, Slovenian, Finnish, Swedish